TAKEDA HELLAS

Takeda is a leading R&D-driven biopharmaceutical company with a history of more than two centuries headquartered in Tokyo Japan with a presence in 80 countries. and more than 15,500 people working across 37 countries in Europe dedicated to helping patients with limited or no treatment options in our core therapeutic and business areas of gastroenterology and inflammation, rare diseases, plasma derived therapies, oncology, neuroscience, and vaccines. Takeda continues to leverage science and partnerships to develop new therapies that address unmet patient need. In addition, our ambition is to develop and scale personalized, predictive digital health and patient solutions with a value-based partnership approach. What makes Takeda different is our approach to making business decisions, founded on Patient-Trust-Reputation-Business. In every decision, our patients come first. It is this framework that allows us to translate our purpose and values into action every day to ensure patient populations, with unmet needsget access to the adequate treatment.